๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Malignant lymphomas in children in the Netherlands in the period 1973-1985: Incidence in relation to leukemia: A report from the dutch childhood leukemia study group

โœ Scribed by Coebergh, Jan Willem W. ;van der Does-van den Berg, Anna ;Kamps, Willem A. ;Rammeloo, Johan A. ;Valkenburg, Hans A. ;van Wering, Elisabeth R.


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
459 KB
Volume
19
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

โœฆ Synopsis


A retrospective study was done of the incidence of non-Hodgkin's lymphoma (NHL) in children in the Netherlands in the period 1973-85 in relation to that of acute lymphoblastic leukemia (ALL). Complete ascertainment of cases was most likely achieved through the network of cooperating pediatricians of the Dutch Childhood Leukemia Study Group (DCLSG). The incidence of NHL remained constant at 0.75 per 10(5) children per year; the boy/girl ratio was 2.5. In +/- 25% of cases the disease was localized at diagnosis. Of children with NHL who were not listed in the DCLSG leukemia register, 19% had greater than or equal to 25% lymphoblasts in the bone marrow at diagnosis, representing an overlap with ALL of +/- 5%. In 1% of the children with NHL an immuno-deficiency disorder preceded the diagnosis. The incidence of Hodgkin's disease (HD) was 0.3 per 10(5) children per year, with some fluctuation over time, the peak being 0.7 in 1983. The boy/girl ratio was 2.7. Age-specific incidence rates, clinical features of NHL and HD, as well as the ALL to NHL ratio corresponded with those in other European countries and for white children in the USA.


๐Ÿ“œ SIMILAR VOLUMES


Improvement in CNS protective treatment
โœ Tsurusawa, Masahito; Katano, Naoyuki; Yamamoto, Yoshifumi; Hirota, Takahisa; Koi ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 126 KB ๐Ÿ‘ 3 views

Background. Prevention of central nervous system (CNS) leukemia by early introduction of therapy to this sanctuary site is an essential component of modern treatment strategy for acute lymphoblastic leukemia (ALL). However, the optimal form of preventive CNS therapy remains debatable. Procedure. To

Improvement in outcome for children with
โœ Jonathan D. Buckley; Ronald L. Chard; Robert L. Baehner; Mark E. Nesbit; Beatric ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 888 KB

The Childrens Cancer Study Group conducted four therapeutic studies on a total of 1006 children with acute nonlymphocytic leukemia from 1972 to 1983. This report describes the therapeutic strategies of these studies and examines trends in induction rates and long-term outcome over this period. The r

Successful reinduction therapy with amsa
โœ Linda P. Miller; Allan F. Pyesmany; Lawrence J. Wolff; Paul C. J. Rogers; Stuart ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 644 KB

Amsacrine (AMSA) and cyclocytidine were studied as retrieval therapy in 122 pediatric patients with acute nonlymphoblastic leukemia (ANLL). Patients either failed to achieve sustained initial remissions or were in relapse. Induction therapy consisted of intravenous (IV) AMSA (75 mg/mz) from days 1 t